ModellaAI
@modella_ai
At Modella AI, we pioneer multimodal, generative, and agentic AI for diagnostic, prognostic, and therapeutic workflows in biomedicine.
🚀 We’re excited to introduce Judith, our AI-driven research assistant agent for biomedical image analysis! ✨ Judith is the first research-use AI agent designed to independently execute biomedical image analysis workflows for scientific discovery. It empowers researchers to…
🤩 We're excited to head to #JPM2025 next week 1/13-1/16 in San Francisco, CA! 🌟 We are particularly excited to attend with Gabi Raia @raiagabi as our newly appointed Chief Commercial Officer! Gabi will be driving commercial strategy and execution, developing strategic…

📢 We’re excited to share that @modella_ai has entered a multi-year partnership with @AstraZeneca 🤝 to accelerate the use of 🧠 AI foundation models in 🧬 oncology R&D. 📈 Faster trials, smarter insights, better outcomes. 🔗 Read more: modella.ai/az-oncology-cl… A big thank…

🤩 We are heading to Chicago for #AACR2025 on April 25-30 with the crew! 💡Join us at booth #4540 to see how Judith, PathChatᵀᴹ, and SlideSearchᵀᴹ are transforming pathology workflow in action! 📧 As always, drop us a line at [email protected] to schedule a 1:1 chat! We…

🤩 We’re thrilled to attend #USCAP2025 March 22nd - 27th with the crew! 💡 Stop by booth 641 to see how Judith and PathChatᵀᴹ revolutionize AI model development and pathology workflows. 🦾 📧 Want to connect 1:1? Drop us a line at [email protected] to schedule a chat! We can’t…

🤩 Curious about PathChat™ DX that received Breakthrough Device Designation from the FDA? Come see the demo live in Santa Clara, CA next week as we head to the @PMWCintl - Precision Medicine World Conference 2025 February 5-7! 🌟 While you're at it, don’t miss Dr. @MYLu97's…

🎉✨We are excited to report that PathChat™ DX, our clinical-grade, generative AI co-pilot for pathology, has officially received Breakthrough Device Designation from the FDA! This marks a pivotal step forward in our quest to transform biomedicine with generative and agentic…
🥂 #JPM2025 was a huge success for Modella AI! It was a busy week for us but still found time to have a little fun too! @jill_stefanelli @raiagabi #generativeai #agenticai #PathChat #Judith #SlideSearch #ModellaAI


We are thrilled to share that our CEO @jill_stefanelli has been featured as one of the 25 Women of Precision Medicine for 2025! This reflects not only her exceptional leadership but also the critical work we are doing at Modella AI in pushing the boundaries in precision…

We had a blast at #PathVisions24 seeing everyone! The ecosystem for pathology is thriving, and we were amazed by the number of people that we had a chance to share and demonstrate Judith and PathChat! Curious about Judith or PathChat? Visit modella.ai to check out…



We are excited to head to #PathVisions24 next week November 3-5 in Orlando, FL!🤩 🔥 Discover how Judith and PathChat can automate your AI model development and enhance your workflow! Reach out to us at [email protected] to book a meeting or come by booth #502 for a live demo. 😎…

🔬🧬 Showcasing our newest #AI #agent, Judith, that can integrate #pathology, #genomics, and #molecular data for #multimodal and interpretable cancer prognosis! ⚡ Ready to use Judith to learn more about your data? Sign up now at modella.ai
The in-print version of the PathChat @Nature article is now available online with open access nature.com/articles/s4158… learn more about next steps and how PathChat is further being developed at @modella_ai
We are excited to attend #ECP2024 by @ESP_Pathology in Florence, Italy, from September 7th-11th! 🤩 🔥 Connect with us and explore how PathChat and our upcoming products can transform your workflow! Reach out to us at [email protected] to schedule a meeting. 🔬 Catch our…

🚀Exciting new! Join us at @DDXSUMMIT this September with @modella_ai President & CEO @jill_stefanelli discussing how conversational generative AI for medical imaging can revolutionize patient care. Visit Modella's booth to learn more! lumeadigital.com/ddxsummit/ #heathcare…
